首页 › 基金 › PEAK FINANCIAL ADVISORS LLC › CTMX

PEAK FINANCIAL ADVISORS LLC 对 CTMX 的持仓历史

CYTOMX THERAPEUTICS INC. · 医疗保健

PEAK FINANCIAL ADVISORS LLC 在 Q3 2026 的 13F 申报中披露持有 CTMX(CYTOMX THERAPEUTICS INC.)462,061 股,市值约 US$1.3M,约占其申报组合的 0.54%,在其申报持仓中市值排名第 44 位。 PEAK FINANCIAL ADVISORS LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)462.06K 股
申报持仓市值$1.26M
组合权重0.54%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

PEAK FINANCIAL ADVISORS LLC 对 CTMX 的持仓演变

PEAK FINANCIAL ADVISORS LLC 于 Q3 2026 首次披露 CTMX 持仓:462,061 股(约 US$1.3M)。

逐季持仓明细

季度股数金额变化
Q3 2026 462.06K $1.26M 新进

关于 CTMX 与 13F 数据

CTMX(CYTOMX THERAPEUTICS INC.)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 CTMX,申报仓位最大的包括:Kynam Capital Management, LP (US$81.4M), PERCEPTIVE ADVISORS LLC (US$39.1M), Venrock Adviser, LLC (US$18.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CTMX 的基金

查看 CTMX 的全部基金持有人 →

常见问题

How long has PEAK FINANCIAL ADVISORS LLC held CTMX?

PEAK FINANCIAL ADVISORS LLC has disclosed CTMX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is PEAK FINANCIAL ADVISORS LLC's current position in CTMX?

As of Q3 2026, PEAK FINANCIAL ADVISORS LLC holds 462.06K shares of CTMX (CYTOMX THERAPEUTICS INC.), valued at $1.26M, representing 0.54% of its reported portfolio and ranking #44.

Has PEAK FINANCIAL ADVISORS LLC been buying or selling CTMX?

In the latest 13F filing (Q3 2026), PEAK FINANCIAL ADVISORS LLC newly opened its position in CTMX.

Which other funds hold CTMX?

Other major institutional holders of CTMX include Kynam Capital Management, LP, PERCEPTIVE ADVISORS LLC, Venrock Adviser, LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.